Inactivation of chemotactic factor inactivator by cigarette smoke: A potential mechanism of modulating neutrophil recruitment to the lung

R. A. Robbins, G. L. Gossman, K. J. Nelson, S. Koyama, Austin Bassett Thompson, S. I. Rennard

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Activation of the complement system with generation of the potent neutrophil chemotactic factor C5a has been proposed to play a significant role in the neutrophil accumulation in the lungs of cigarette smokers. Chemotactic factor inactivator (CFI) can inhibit C5a-directed neutrophil chemotaxis by binding to the C5a cochemotaxin GcGlobulin (GcG), a vitamin-D-binding protein, and inhibiting the capacity of GcG to enhance the chemotactic activity of C5a. Because cigarette smoke can inhibit the function of some proteins, a loss of CFI functional activity induced by cigarette smoke would allow an increased capacity of GcG to augment C5a-directed neutrophil chemotaxis. In order to test this hypothesis, cigarette smoke was bubbled through a CFI solution, and the solution was evaluated for its ability to inhibit the chemotactic activity of C5a and GcG. Smoke-treated CFI inhibited only 36% of the C5a-GcG chemotactic activity. In contrast, a CFI solution treated with air inhibited 62% of the chemotactic activity (p < 0.001). Consistent with these observations, smoke-treated CFI exhibited a decreased capacity to bind to GcG and a decreased capacity to inhibit the binding of C5a des Arg to GcG. CFI contained in the bronchial lavage fluids obtained from patients with chronic obstructive pulmonary disease secondary to cigarette smoking and asymptomatic smokers exhibited a decreased capacity to inhibit C5a-GcG neutrophil chemotaxis and to bind to GcG (p < 0.05, both comparisons). Furthermore, smoke bubbled through normal bronchial lavage fluid decreased the capacity of CFI to bind to GcG. These data suggest that one mechanism accounting for an influx of neutrophils into the lungs of cigarette smokers may be a loss of functional activity of CFI secondary to cigarette smoke.

Original languageEnglish (US)
Pages (from-to)763-768
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume142
Issue number4
DOIs
StatePublished - Jan 1 1990

Fingerprint

Neutrophil Infiltration
Smoke
Tobacco Products
Lung
Neutrophils
Chemotaxis
Bronchoalveolar Lavage Fluid
des-Arginine Complement C5a
Vitamin D-Binding Protein
chemotactic factor inactivator
Aptitude
Complement Activation
Interleukin-8
Chronic Obstructive Pulmonary Disease
Smoking
Air

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Inactivation of chemotactic factor inactivator by cigarette smoke : A potential mechanism of modulating neutrophil recruitment to the lung. / Robbins, R. A.; Gossman, G. L.; Nelson, K. J.; Koyama, S.; Thompson, Austin Bassett; Rennard, S. I.

In: American Review of Respiratory Disease, Vol. 142, No. 4, 01.01.1990, p. 763-768.

Research output: Contribution to journalArticle

@article{7c4506b3a3244e08b35186ce409322ea,
title = "Inactivation of chemotactic factor inactivator by cigarette smoke: A potential mechanism of modulating neutrophil recruitment to the lung",
abstract = "Activation of the complement system with generation of the potent neutrophil chemotactic factor C5a has been proposed to play a significant role in the neutrophil accumulation in the lungs of cigarette smokers. Chemotactic factor inactivator (CFI) can inhibit C5a-directed neutrophil chemotaxis by binding to the C5a cochemotaxin GcGlobulin (GcG), a vitamin-D-binding protein, and inhibiting the capacity of GcG to enhance the chemotactic activity of C5a. Because cigarette smoke can inhibit the function of some proteins, a loss of CFI functional activity induced by cigarette smoke would allow an increased capacity of GcG to augment C5a-directed neutrophil chemotaxis. In order to test this hypothesis, cigarette smoke was bubbled through a CFI solution, and the solution was evaluated for its ability to inhibit the chemotactic activity of C5a and GcG. Smoke-treated CFI inhibited only 36{\%} of the C5a-GcG chemotactic activity. In contrast, a CFI solution treated with air inhibited 62{\%} of the chemotactic activity (p < 0.001). Consistent with these observations, smoke-treated CFI exhibited a decreased capacity to bind to GcG and a decreased capacity to inhibit the binding of C5a des Arg to GcG. CFI contained in the bronchial lavage fluids obtained from patients with chronic obstructive pulmonary disease secondary to cigarette smoking and asymptomatic smokers exhibited a decreased capacity to inhibit C5a-GcG neutrophil chemotaxis and to bind to GcG (p < 0.05, both comparisons). Furthermore, smoke bubbled through normal bronchial lavage fluid decreased the capacity of CFI to bind to GcG. These data suggest that one mechanism accounting for an influx of neutrophils into the lungs of cigarette smokers may be a loss of functional activity of CFI secondary to cigarette smoke.",
author = "Robbins, {R. A.} and Gossman, {G. L.} and Nelson, {K. J.} and S. Koyama and Thompson, {Austin Bassett} and Rennard, {S. I.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1164/ajrccm/142.4.763",
language = "English (US)",
volume = "142",
pages = "763--768",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Inactivation of chemotactic factor inactivator by cigarette smoke

T2 - A potential mechanism of modulating neutrophil recruitment to the lung

AU - Robbins, R. A.

AU - Gossman, G. L.

AU - Nelson, K. J.

AU - Koyama, S.

AU - Thompson, Austin Bassett

AU - Rennard, S. I.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Activation of the complement system with generation of the potent neutrophil chemotactic factor C5a has been proposed to play a significant role in the neutrophil accumulation in the lungs of cigarette smokers. Chemotactic factor inactivator (CFI) can inhibit C5a-directed neutrophil chemotaxis by binding to the C5a cochemotaxin GcGlobulin (GcG), a vitamin-D-binding protein, and inhibiting the capacity of GcG to enhance the chemotactic activity of C5a. Because cigarette smoke can inhibit the function of some proteins, a loss of CFI functional activity induced by cigarette smoke would allow an increased capacity of GcG to augment C5a-directed neutrophil chemotaxis. In order to test this hypothesis, cigarette smoke was bubbled through a CFI solution, and the solution was evaluated for its ability to inhibit the chemotactic activity of C5a and GcG. Smoke-treated CFI inhibited only 36% of the C5a-GcG chemotactic activity. In contrast, a CFI solution treated with air inhibited 62% of the chemotactic activity (p < 0.001). Consistent with these observations, smoke-treated CFI exhibited a decreased capacity to bind to GcG and a decreased capacity to inhibit the binding of C5a des Arg to GcG. CFI contained in the bronchial lavage fluids obtained from patients with chronic obstructive pulmonary disease secondary to cigarette smoking and asymptomatic smokers exhibited a decreased capacity to inhibit C5a-GcG neutrophil chemotaxis and to bind to GcG (p < 0.05, both comparisons). Furthermore, smoke bubbled through normal bronchial lavage fluid decreased the capacity of CFI to bind to GcG. These data suggest that one mechanism accounting for an influx of neutrophils into the lungs of cigarette smokers may be a loss of functional activity of CFI secondary to cigarette smoke.

AB - Activation of the complement system with generation of the potent neutrophil chemotactic factor C5a has been proposed to play a significant role in the neutrophil accumulation in the lungs of cigarette smokers. Chemotactic factor inactivator (CFI) can inhibit C5a-directed neutrophil chemotaxis by binding to the C5a cochemotaxin GcGlobulin (GcG), a vitamin-D-binding protein, and inhibiting the capacity of GcG to enhance the chemotactic activity of C5a. Because cigarette smoke can inhibit the function of some proteins, a loss of CFI functional activity induced by cigarette smoke would allow an increased capacity of GcG to augment C5a-directed neutrophil chemotaxis. In order to test this hypothesis, cigarette smoke was bubbled through a CFI solution, and the solution was evaluated for its ability to inhibit the chemotactic activity of C5a and GcG. Smoke-treated CFI inhibited only 36% of the C5a-GcG chemotactic activity. In contrast, a CFI solution treated with air inhibited 62% of the chemotactic activity (p < 0.001). Consistent with these observations, smoke-treated CFI exhibited a decreased capacity to bind to GcG and a decreased capacity to inhibit the binding of C5a des Arg to GcG. CFI contained in the bronchial lavage fluids obtained from patients with chronic obstructive pulmonary disease secondary to cigarette smoking and asymptomatic smokers exhibited a decreased capacity to inhibit C5a-GcG neutrophil chemotaxis and to bind to GcG (p < 0.05, both comparisons). Furthermore, smoke bubbled through normal bronchial lavage fluid decreased the capacity of CFI to bind to GcG. These data suggest that one mechanism accounting for an influx of neutrophils into the lungs of cigarette smokers may be a loss of functional activity of CFI secondary to cigarette smoke.

UR - http://www.scopus.com/inward/record.url?scp=0025036344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025036344&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/142.4.763

DO - 10.1164/ajrccm/142.4.763

M3 - Article

C2 - 2221580

AN - SCOPUS:0025036344

VL - 142

SP - 763

EP - 768

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -